CDEK by Data4ThePeople
Sign in Sign up
← All organizations

Amneal Pharmaceuticals

For profitWebsite ↗

Also known as: AMNEAL | AMNEAL EU LTD | Amneal Ireland Limited | AMNEAL IRELAND LIMITED | AMNEAL IRELAND LTD | AMNEAL PHARM | Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals, LLC | AMNEAL PHARMS | AMNEAL PHARMS CO | AMNEAL PHARMS LLC | AMNEAL PHARMS NY | AMNEALS PHARMS | IPR

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Dec 1, 2009

First marketed drug

Jul 1, 2002

Last known activity

Jun 2, 2026

Timeline

2000s

  1. Jul 1, 2002

    Amneal Pharmaceuticals— Founded

2010s

  1. Apr 8, 2016

    raloxifene— Marketing Organization

  2. Oct 1, 2017

    Impax LaboratoriesImpax Laboratories— Acquired

  3. Aug 2, 2018

    tigecycline— NDA Secondary Org

2020s

  1. Dec 20, 2020

    AmDerma— Acquired

Drugs by trial phase (26 distinct, 44 trials)

Phase 4 (0 own, 1 via acquisition)

Phase 2 (0 own, 3 via acquisition)

Phase 1 (1 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (317)

Subsidiaries (2 direct, 5 total across the full acquisition tree)

Recent trials (23)

Details

Founded
Bridgewater, NJ, US Jul 1, 2002
Last known activity
Jun 2, 2026